Kinetics of cytokine receptor trafficking determine signaling and functional selectivity

Author:

Martinez-Fabregas Jonathan1ORCID,Wilmes Stephan1ORCID,Wang Luopin2ORCID,Hafer Maximillian3ORCID,Pohler Elizabeth1,Lokau Juliane4ORCID,Garbers Christoph4,Cozzani Adeline5,Fyfe Paul K1,Piehler Jacob3ORCID,Kazemian Majid2ORCID,Mitra Suman5ORCID,Moraga Ignacio1ORCID

Affiliation:

1. Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom

2. Department Computer Science, Purdue University, West Lafayette, United States

3. Department of Biology, University of Osnabrück, Osnabrück, Germany

4. Department of Pathology, Medical Faculty, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany

5. INSERM UMR-S-11721, Centre de Recherche Jean-Pierre Aubert (JPARC), Institut pour la Recherche sur le Cancer de Lille (IRCL), Université de Lille, Lille, France

Abstract

Cytokines activate signaling via assembly of cell surface receptors, but it is unclear whether modulation of cytokine-receptor binding parameters can modify biological outcomes. We have engineered IL-6 variants with different affinities to gp130 to investigate how cytokine receptor binding dwell-times influence functional selectivity. Engineered IL-6 variants showed a range of signaling amplitudes and induced biased signaling, with changes in receptor binding dwell-times affecting more profoundly STAT1 than STAT3 phosphorylation. We show that this differential signaling arises from defective translocation of ligand-gp130 complexes to the endosomal compartment and competitive STAT1/STAT3 binding to phospho-tyrosines in gp130, and results in unique patterns of STAT3 binding to chromatin. This leads to a graded gene expression response and differences in ex vivo differentiation of Th17, Th1 and Treg cells. These results provide a molecular understanding of signaling biased by cytokine receptors, and demonstrate that manipulation of signaling thresholds is a useful strategy to decouple cytokine functional pleiotropy.

Funder

Horizon 2020 Framework Programme

EMBO

National Heart, Lung, and Blood Institute

Wellcome Trust

Royal Society

Contrat de Plan Etat Région Hauts de France and Institut pour la Recherche sur le Cancer de Lille

Deutsche Forschungsgemeinschaft

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3